(Q41202524)

28 September 2017

title

Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin (English)

1 reference

28 September 2017

0 references

1 reference

Jain N

1

1 reference

28 September 2017

Lam YM

series ordinal

2

1 reference

28 September 2017

Pym J

series ordinal

3

1 reference

28 September 2017

Campling BG

series ordinal

4

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 May 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

77

1 reference

28 September 2017

issue

9

1 reference

28 September 2017

page(s)

1797-1808

1 reference

describes a project that uses

28 September 2017

H209/CP

0 references

H209/VP

0 references

cites work

VP-16 and cisplatin as first-line therapy for small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Current status of etoposide in the management of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Fundamental studies with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Characterization of an etoposide-resistant human small-cell lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Multiple mechanisms of resistance in a series of human testicular teratoma cell lines selected for increasing resistance to etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Cellular accumulation of the anticancer agent cisplatin: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Overexpression of metallothionein confers resistance to anticancer drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Chemosensitivity testing of small cell lung cancer using the MTT assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

A simplification of the protein assay method of Lowry et al. which is more generally applicable

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Design of DNA intercalators to overcome topoisomerase II-mediated multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Purification and characterization of an altered topoisomerase II from a drug-resistant Chinese hamster ovary cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

cis-diamminedichloroplatinum (II) (cisplatin) alters microtubule assembly dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Establishment and characterization of cisplatin-resistant sublines of human lung cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Radiation response of human lung cancer cells with inherent and acquired resistance to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Determinants of drug response in a cisplatin-resistant human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Characteristics of five human tumor cell lines and sublines resistant to cis-diamminedichloroplatinum(II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Levels of glutathione S transferase pi mRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Quantitative aspects of the formation and loss of DNA interstrand crosslinks in Chinese hamster cells following treatment with cis-diamminedichloroplatinum(II) (cisplatin). I. Proportion of DNA-platinum reactions involved in DNA crosslinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Altered expression and transcription of the topoisomerase II gene in nitrogen mustard-resistant human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Determinants of Response to the DNA Topoisomerase II Inhibitors Doxorubicin and Etoposide in Human Lung Cancer Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819960501%2977%3A9%3C1797%3A%3AAID-CNCR7%3E3.0.CO%3B2-9

10.1002/(SICI)1097-0142(19960501)77:9<1797::AID-CNCR7>3.0.CO;2-9

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference